AMPHASTAR PHARMACEUTICALS IN

AMPH · NASDAQ

Updated at 2026-11-16 20:46:21

$29.29-0.27%
Today's High
$30.11
Today’s Low
$29.17
AMPHASTAR PHARMACEUTICALS IN (AMPH) Stock Price & Market Data
Search empty state illustration
...

Candlestick trends are for reference. Refer to the trading page for actual data.

Key Statistics

Previous Open
$29.05
Previous Close
$29.37
Volume
380.76K
Market Cap
$1.25B
P/E Ratio
15.94X
EPS
$1.70

Previous Day Range

$28.84$29.73

52-Week Range

$16.65$31.00

Company Overview

Sector
HEALTHCARE
Industry
Pharmaceuticals
Sub-industry
DRUG MANUFACTURERS - SPECIALTY & GENERIC
Headquarters
11570 6TH STREET, RANCHO CUCAMONGA, CA, UNITED STATES, 91730
Country
US
Listing Date
2014-06-25
Fiscal Year End
December
Shares Outstanding
42.54M
CIK
0001297184

Amphastar Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company is headquartered in Rancho Cucamonga, California.

Financial Metrics

Revenue

2026-09-30

$207.6M

2026-06-30

$183.9M

2026-03-31

$171.17M

2025-12-31

$183.1M

Operating Expenses

2026-09-30

$48.85M

2026-06-30

$53.74M

2026-03-31

$56.69M

2025-12-31

$50.06M

Net Income

2026-09-30

$37.76M

2026-06-30

$30.34M

2026-03-31

$6.42M

2025-12-31

$24.42M

Net Profit Margin

2026-09-30

18.18%

2026-06-30

16.5%

2026-03-31

3.75%

2025-12-31

13.34%

Earnings Per Share

2026-09-30

$1.01

2026-06-30

$0.80

2026-03-31

$0.42

2025-12-31

$0.61

Earnings Before Interest, Taxes, Depreciation, and Amortization

2026-09-30

$71.4M

2026-06-30

$61.66M

2026-03-31

$33.09M

2025-12-31

$54.53M

Effective Tax Rate

2026-09-30

23.03%

2026-06-30

21.26%

2026-03-31

36.13%

2025-12-31

23.45%

FAQs

Risk Warning

Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.